Memory Test  Play Games
(exercise your mind)

  How the Brain Creates the Mind's Eye: New Research

Jan. 18 (United States)  
 
























Charles Connor, Associate Professor
Johns Hopkins University


Wednesday, January 18 (CogLabs Newswire)

When a human looks at a number, letter or other shape, neurons in various areas of the brain's visual center respond to different components of that shape, almost instantaneously fitting them together like a puzzle to create an image that the individual then "sees" and understands, researchers at The Johns Hopkins University report.

A team from the university's Zanvyl Krieger Mind/Brain Institute describes the complex but speedy process in detail in a recent issue of the journal Neuron.

The question of how the brain sees, recognizes and understands objects is one of the most intriguing in neuroscience, associate professor and paper co-author Charles E. Connor said.

"This may not even seem like a scientific question to some people, because seeing is so automatic and we are so good at it – far better than the best computer vision systems yet devised," Connor said. "That is because a large part of the human brain is devoted to interpreting objects in our world, so that we have the necessary information for interacting with our environment.

"Vision doesn't happen in the eye," Connor said. "It happens at multiple processing stages in the brain. We study how objects are signaled or encoded by large populations of neurons at higher-level stages in the object-processing part of the brain."

The report, based on recordings of nerve cells in the visual cortex of macaque monkeys, reveals that neurons in the higher-level visual cortex at first respond to a visual stimulus "somewhat indiscriminately," signaling all the individual features within a shape to which they are sensitive. For instance, a particular neuron may respond to objects with either a concave fragment at the top or a convex fragment at the bottom. At this point, the neural signals are ambiguous; the brain doesn't know whether the concavity, the convexity or both are present.

Milliseconds later, however, neurons begin to react exclusively to combinations of shape fragments, rather than to individual fragments. In other words, the brain begins to put the pieces together to form larger sections, in the same way that an artisan might fasten discrete shards of stained glass to create a design.

"Humans do a rough categorization of objects very quickly," Connor said. "For instance, in just a tenth of a second, we can recognize whether something we see is an animal or not. Our results show that this immediate, rough impression probably depends on recognizing just one or more individual parts of what we see. Fine discriminations – such as recognizing individual faces – take longer to happen, and our study suggests that this delay depends upon emerging signals for combinations of shape fragments. In a sense, the brain has to construct an internal representation of an object from disparate pieces."

In the long term, understanding exactly how the brain processes information may lead to neural prostheses – artificial replacements for lost sensory, motor and perhaps even memory and cognitive functions. In the short term, such work is driven by curiosity about one of the fundamental mysteries: how the brain works.

"Our ability to see is one of the great evolutionary accomplishments of the human brain," Connor said. "We still don't know how the visual system accomplishes this marvel of information processing. Such experiments are beginning to reveal

More information


Alzheimer's

Is there any treatment?

There is no cure for AD and no way to slow the progression of the disease. For some people in the early or middle stages of AD, medication such as tacrine (Cognex) may alleviate some cognitive symptoms. Donepezil (Aricept), rivastigmine (Exelon), and galantamine (Reminyl) may keep some symptoms from becoming worse for a limited time. A fifth drug, memantine (Namenda), was recently approved for use in the United States. Combining memantine with other AD drugs may be more effective than any single therapy. One controlled clinical trial found that patients receiving donepezil plus memantine had better cognition and other functions than patients receiving donepezil alone. Also, other medications may help control behavioral symptoms such as sleeplessness, agitation, wandering, anxiety, and depression. Prevention, through lifestyle changes and mental and physcial exercise, represents one of the best ways to reduce the likelihood of getting the disease, coupled with regular, systematic monitoring.  

What is the prognosis?

AD is a progressive disease, but its course can vary from 5 to 20 years. The most common cause of death in AD patients is infection.  As the population ages and other diseases are brought under control - Alzheimer's becomes a major risk.

What research is being done?


Scientists are currently studying or testing different types of drugs and other substances to determine if they can stop AD progression, including nonsteroidal anti-inflammatory drugs (NSAIDS), statins (such as those used for lowering cholesterol), folic acid, gingko biloba, huperzine, and vitamins E, B6, and B12. Studies in basic science are also exploring the potential of vaccines. Regular  'screenings' are being advocated by some - with the U.S. House of Representatives recently passing a bill in support of early memory check-ups.  All advocate a regimen of physical exercise and mental exercise. If you start an exercise regimen or just walking use MemCheck to track your progress.

Read testimonials from scientists and physicians on MemCheck.
  Give Memory For Life as a Gift for a loved one. Actions taken today help tomorrow.
Give the Gift of TV - Cognitive Labs and Microsoft are partnering on a special offer.

Source: NIH and Cognitive Advisors. For a qualified medical opinion or diagnosis, please see your healthcare provider.  

Famous People and Alzheimers: former President Ronald Reagan, Grambling University football coach Eddie Robinson, actor Charlton Heston, actor James Doohan.